Pre-operative application of Teltivudine to improve hepatic function in patients with Primary hepatic cancer and positive HBV-DNA of low-concentration.
Phase of Trial: Phase II
Latest Information Update: 01 May 2013
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Actual end date (31 Oct 2011) added as reported by Chinese Clinical Trial Register.
- 21 Feb 2012 Status changed from recruiting to completed as reported by China Clinical Trials Register record.
- 31 Dec 2009 New trial record